Results 141 to 150 of about 39,421 (210)

Genetic Targeting of Adenoviral Vectors

Molecular Therapy, 2000
Krasnykh, Victor N., Douglas, Joanne T., van Beusechem, Victor W.   +2 more
openaire   +2 more sources

Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus. [PDF]

NPJ Vaccines
Fuchs J, Hübner J, Schmidt A, Irrgang P, Maier C, Vieira Antão A, Oltmanns F, Thirion C, Lapuente D, Tenbusch M.   +9 more
europepmc   +1 more source

Combined delivery of IL12 and an IL18 mutant without IL18BP-binding activity by an adenoviral vector enhances tumor specific immunity. [PDF]

Sci Rep
Cheng Y, Luo R, Li E.
europepmc   +1 more source

A replication-incompetent adenoviral vector encoding for HSV-2 gD2 is immunogenic and protective against HSV-2 intravaginal challenge in mice. [PDF]

PLoS One
Rossetti E, Vujadinovic M, van Huizen E, Tolboom J, Schuitemaker H, Yao F, Zahn R, Saeland E.   +7 more
europepmc   +1 more source

Humoral Immune Response in Immunized Sheep with Bovine Coronavirus Glycoproteins Delivered via an Adenoviral Vector. [PDF]

Pathogens
Pratelli A, Capozza P, Minesso S, Lucente MS, Pellegrini F, Tempesta M, Franceschi V, Buonavoglia C, Donofrio G.   +8 more
europepmc   +1 more source

Comparative Biodistribution Study of Baculoviral and Adenoviral Vector Vaccines against SARS-CoV-2. [PDF]

J Microbiol Biotechnol
Lee HD, Chun J, Kim S, Aleksandra N, Lee C, Yoon D, Lee HJ, Kim YB.   +7 more
europepmc   +1 more source

Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults. [PDF]

Vaccine
Honda-Okubo Y, Sajkov D, Wauchope B, Turner JV, Vote B, Antipov A, André G, Lebedin Y, Petrovsky N.   +8 more
europepmc   +1 more source

Optimization of Culture Media and Feeding Strategy for High Titer Production of an Adenoviral Vector in HEK 293 Fed-Batch Culture. [PDF]

Vaccines (Basel)
Shen CF, Rodenbrock A, Lanthier S, Burney E, Loignon M.   +4 more
europepmc   +1 more source

Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines. [PDF]

Sci Immunol
Murray SM, Amini A, Ferry H, Garner LC, Pudjohartono MF, Kronsteiner B, Bibi S, Pollard AJ, Barnes E, Lambe T, Dunachie S, Klenerman P, Provine NM.   +12 more
europepmc   +1 more source

Pandemic-response adenoviral vector and RNA vaccine manufacturing

, 2021
Kis Z, Tak K, Ibrahim D, Papathanasiou MM, Chachuat B, Shah N, Kontoravdi C.   +6 more
europepmc   +1 more source